Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950103-12-003139
Filing Date
2012-06-15
Accepted
2012-06-15 06:02:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G dp30770_sc13g.htm SC 13G 70351
  Complete submission text file 0000950103-12-003139.txt   71875
Mailing Address MITA NN BLDG. 4-1-23 SHIBA, MINATO-KU TOKYO M0 105 6135
Business Address MITA NN BLDG. 4-1-23 SHIBA, MINATO-KU TOKYO M0 105 6135 81354195000
ORIX CORP (Filed by) CIK: 0001070304 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0331
Type: SC 13G
SIC: 6159 Miscellaneous Business Credit Institution

Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Subject) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83614 | Film No.: 12908746
SIC: 2834 Pharmaceutical Preparations